Clinical trial

Autism Spectrum Disorder (ASD) and Intellectual Disability (ID) Determinants in Tuberous Sclerosis Complex (TSC)

NCT02461459

StatusACTIVE_NOT_RECRUITING

Study typeOBSERVATIONAL

Start date2015-05-01

PhaseN/A

Study timeline

Study start (unknown)2015-05-01Date precision: month

Registry last updated2026-08-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Tuberous Sclerosisunresolved

Autism Disorderunresolved

Intellectual Disabilityunresolved

Interventions

Sponsors & collaborators

Boston Children's Hospitallead sponsor

National Institutes of Health (NIH)collaborator

National Institute of Neurological Disorders and Stroke (NINDS)collaborator

Tuberous Sclerosis Alliancecollaborator

National Center for Advancing Translational Sciences (NCATS)collaborator

Office of Rare Diseases (ORD)collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)collaborator

Mapped research locations

HoustonTexas, United States1 BostonMassachusetts, United States1 Los AngelesCalifornia, United States1 BirminghamAlabama, United States1 CincinnatiOhio, United States1 Palo AltoCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02461459 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.